NM_173841.3:c.215-516ATCCTGGGGAAAGTGAGGGAAATATGGACATCACATGGAACAACATCCAGGAGACTCAGGCCTCTAGGAGTAACTGGGTAGTGTGC[4]

  1. Home
  2. NM_173841.3:c.215-516ATCCTGGGGAAAGTGAGGGAAATATGGACATCACATGGAACAACATCCAGGAGACTCAGGCCTCTAGGAGTAACTGGGTAGTGTGC[4]

HGVS Expressions

  • NG_021240.1:g.17637ATCCTGGGGAAAGTGAGGGAAATATGGACATCACATGGAACAACATCCAGGAGACTCAGGCCTCTAGGAGTAACTGGGTAGTGTGC[4]
  • NM_173841.3:c.215-516ATCCTGGGGAAAGTGAGGGAAATATGGACATCACATGGAACAACATCCAGGAGACTCAGGCCTCTAGGAGTAACTGGGTAGTGTGC[4]
  • NC_000002.12:g.113130529ATCCTGGGGAAAGTGAGGGAAATATGGACATCACATGGAACAACATCCAGGAGACTCAGGCCTCTAGGAGTAACTGGGTAGTGTGC[4]

Associated Genes

Interleukin 1 Receptor Antagonist
Back to search Result
CTGA Clinical Significance

Association

Variant Type

Reference Allele

dbSNP

2234663

Epidemiology in the Arab World

View Map
Subject IDCountry of OriginAllele CountAllele FrequencyCTGA Clinical Significance Condition(s)ReferenceRemarks
125853.G.38.1United Arab Emirates400AssociationType 2 Diabetes MellitusAl-Safar et al. 2015 271 Emiratis with Type 2 DM.
125853.G.38.2United Arab Emirates276Al-Safar et al. 2015 215 healthy controls
Download Table

Contributors

  • Pratibha Nair: 17.05.2022

Edit History

  • Sami Bizzari: 30.01.2023
  • Sayeeda Hana: 13.01.2023
  • Pratibha Nair: 17.05.2022
Back to search Result
© CAGS 2024. All rights reserved.
© CAGS 2024. All rights reserved.